Our tests and services
Our tests and services are all about helping you take control and make decisions about your health.
To find the right test for you, use our filters ‘Hereditary tests’ or ‘Decisions about my treatment’ or simply click on any test box to find out more.
Understanding your likely response or resistance to certain classic chemotherapies and other targeted therapies and immunotherapies is invaluable in planning your treatment. Choose this test if you have Stage IV in Breast HR+/HR2+, Colon, or NSCLC (Non-Small Cell Lung Cancer}.
If you have Stage III of any cancer tumour – or Stage IV in certain conditions, this test can help you identify the best treatment plan for you if. See also our OncoSTRAT&GO test.
This test not only examines your risk of cancer and heart disease, it also analyses genes that can influence how your body processes certain medications including those given for common pain, heart disease, and mental health issues such as anxiety or depression.
Counselling plus pan-cancer Panel
All of us have a 1 in 2 lifetime risk of developing cancer, but some are known to occur more frequently in families, passing down the generations. This test analyses 30 genes associated with the most common hereditary cancers.
This test is about helping you and your clinician determine the best treatment plan for you based on the analysis of your tumour and blood. It looks for the presence of specific biomarkers and can identify how your cancer is likely to respond to classic chemotherapies as well as other targeted therapies and immunotherapies.
Analysing the personal bio-markers in your genes to monitor the effect your drugs or other therapies are having on your cancer is the purpose of this test. It means you can adapt your treatment based on what you learn.
If you have Stage II or Stage III colon cancer, this test can be used to understand the risk of your cancer recurring and therefore enable you make informed decisions about your personal treatment options. It is particularly valuable in assessing whether chemotherapy is necessary or appropriate when you have Stage II colon cancer.
Learn whether PARP inhibitors – one of the latest treatments available – could help you fight ovarian epithelial cancer with this two-gene test focusing on BRCA 1 and BRCA 2.
TumorNext – HRD
Ask about our wider 11-gene test which looks at factors including whether PARP inhibitors – one of the latest treatments available in fighting ovarian epithelial cancer – can help you.
Rapid BRCA 1/2
If you have already been diagnosed with one of the common cancers, this test is a fast track analysis that can help you make vital decisions about your treatment – particularly if you a considering surgical options.
If you’re a woman with early-stage, hormone-receptor-positive breast cancer, this test can help you and your clinician identify the best treatment options for you, particularly around the length of time it’s beneficial to have hormonal therapy.
If you have been diagnosed with the blood cancer, multiple myeloma, this test can help your clinician select the best treatment for you.
Microsatelite instability (MSI) testing
If you have been diagnosed with colorectal or endometrial cancer with abnormal MSI and/or Immunohistochemistry (IHC) results, this test can help you make key decisions about your treatment.
TumorNext-Lynch (8 genes)
If you have been diagnosed with colorectal or endometrial cancer with abnormal MSI and/or IHC results, this test can help inform key treatment decisions.
CustomNext-Cancer (up to 82 genes of your choice)
If you have a complex personal – or family – history of cancer (in other words, have been diagnosed with more than one type of cancer), then this test could help you accurately diagnose, treat and manage the risks to your health.
ProstateNext (14 genes)
If several members of your family have had prostate and other cancers – or maybe you have had a diagnosis yourself, this test is all about early detection, prevention and tailored therapies.
MelanomaNext (8 genes)
If you have had one or more primary melanoma (a type of skin cancer), or maybe there is a history of melanoma or other cancers in your family, this test could be for you.
RenalNext (19 genes)
If several members of your family have had kidney (renal) or thyroid cancers – or maybe kidney or neuroendocrine tumours, this test is all about early detection and risk reduction.
PancNext (13 genes)
If several members of your family have had pancreatic and other cancers – or maybe you have had a diagnosis yourself, this test is all about early detection, prevention and tailored therapies.
OvaNext (25 genes)
Female cancers often appear quietly, masking themselves with non-specific symptoms, making them hard to detect without proper testing. OvaNext looks at your risk of developing hereditary breast, ovarian, or uterine cancer.
Lynch Syndrome Current (5 genes)
Lynch syndrome is the most common cause of hereditary colorectal and uterine cancer. It can also indicate a higher risk of some other cancers including ovarian. This test is all about early detection and cancer prevention.
GYNPlus (13 genes)
This test is looking at gene mutations in women which indicate high or moderate risk of ovarian and uterine cancer.
ColoNext (17 genes)
If several members of your family have had colorectal and other cancers – or maybe you have had a diagnosis yourself, even if it was only for polyps, this test is all about early detection and cancer prevention.
BreastNext (17 genes)
It is estimated that 266,000 women and 2,500 men will be diagnosed with breast cancer this year alone. If you are considered high risk, this specialist 17 gene panel can help you and your clinician assess the most appropriate screening and treatment for you.
BRCAPlus (8 genes)
Some common cancers – breast, melanoma, pancreatic, prostate and ovarian – are known to occur more frequently in families, passing from one generation to the next. This test focuses on certain genes which can indicate additional risk.